{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:38:27Z","timestamp":1792103907676,"version":"4.4.0"},"reference-count":230,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Drug-induced liver injury (DILI) is one of the main causes of acute liver failure in children. Its incidence is probably underestimated, as specific diagnostic tools are currently lacking. Over 1000 known drugs cause DILI, and the list is expanding. The aim of this review is to describe DILI pathogenesis and emphasize the drugs accountable for child DILI in order to aid its recognition. Intrinsic DILI is well described in terms of mechanism, incriminated drugs, and toxic dose. Conversely, idiosyncratic DILI (iDILI) is unpredictable, occurring as a result of a particular response to drug administration, and its occurrence cannot be foreseen in clinical studies. Half of pediatric iDILI cases are linked to antibiotics, mostly amoxicillin\u2013clavulanate, in the immune-allergic group, while autoimmune DILI is the hallmark of minocycline and nitrofurantoin. Secondly, antiepileptics are responsible for 20% of pediatric iDILI cases, children being more prone to iDILI caused by these agents than adults. A similar tendency was observed in anti-tuberculosis drugs, higher incidences being reported in children below three years old. Current data show growing cases of iDILI related to antineoplastic agents, atomoxetine, and albendazole, so that it is advisable for clinicians to maintain a high index of suspicion regarding iDILI.<\/jats:p>","DOI":"10.3390\/ijms26052006","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:55:48Z","timestamp":1740480948000},"page":"2006","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Drug-Induced Liver Injury\u2014Pharmacological Spectrum Among Children"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0147-0230","authenticated-orcid":false,"given":"Bianca Raluca","family":"Maris","sequence":"first","affiliation":[{"name":"2nd Pediatric Discipline, Department of Mother and Child, Faculty of Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"2nd Pediatric Clinic, Emergency Clinical Hospital for Children, 400177 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Grama","sequence":"additional","affiliation":[{"name":"2nd Pediatric Discipline, Department of Mother and Child, Faculty of Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"2nd Pediatric Clinic, Emergency Clinical Hospital for Children, 400177 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-1219","authenticated-orcid":false,"given":"Tudor Lucian","family":"Pop","sequence":"additional","affiliation":[{"name":"2nd Pediatric Discipline, Department of Mother and Child, Faculty of Medicine, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"2nd Pediatric Clinic, Emergency Clinical Hospital for Children, 400177 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.therap.2018.02.004","article-title":"Safety data and withdrawal of hepatotoxic drugs","volume":"76","author":"Babai","year":"2021","journal-title":"Therapies"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gerussi, A., Natalini, A., Antonageli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., and Invernizzi, P. (2021). Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094557"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Liu, W., Zeng, X., Liu, Y., Liu, J., Li, C., Chen, L., Chen, H., and Ouyang, D. (2021). The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.723940"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jee, A., Senoskie, S.C., and Uetrecht, J. (2021). Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062954"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury","volume":"16","author":"Katarey","year":"2016","journal-title":"Clin. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cld.2013.07.002","article-title":"Mechanisms of drug-induced liver injury","volume":"17","author":"Yuan","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrgastro.2011.22","article-title":"Mechanisms of drug-induced liver injury: From bedside to bench","volume":"8","author":"Tujios","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1389200219666180523095355","article-title":"Models of Drug Induced Liver Injury (DILI)\u2014Current Issues and Future Perspectives","volume":"19","author":"Kuna","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_10","unstructured":"Bergen, A. (2023, April 10). Immune-Mediated DILI\u2014Predicting the Unpredictable. Available online: https:\/\/cn-bio.com\/immune-mediated-dili-predicting-the-unpredictable\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MPG.0000000000003535","article-title":"Drug-induced Liver Injury in Pediatrics","volume":"75","year":"2022","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_12","unstructured":"Grogan, S., and Preuss, C.V. (2024, January 14). Pharmacokinetics, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557744\/."},{"key":"ref_13","unstructured":"Susa, S.T., Hussain, A., and Preuss, C.V. (2024, January 14). Drug Metabolism, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442023\/."},{"key":"ref_14","unstructured":"Phang-Lyn, S., and Llerena, V.M. (2024, January 14). Biochemistry, Biotransformation, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544353\/."},{"key":"ref_15","unstructured":"Larson, A.M. (2024, March 15). Drugs and the Liver: Metabolism and Mechanism of Injury. Available online: https:\/\/www.uptodate.com\/contents\/drugs-and-the-liver-metabolism-and-mechanisms-of-injury."},{"key":"ref_16","first-page":"221","article-title":"Pharmacology, Part 2: Introduction to Pharmacokinetics","volume":"46","author":"Curie","year":"2018","journal-title":"JNMT"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apsb.2018.04.003","article-title":"Drug metabolism in drug discovery and development","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.18773\/austprescr.2016.071","article-title":"Paediatric pharmacokinetics and drug doses","volume":"39","year":"2016","journal-title":"Aust. Prescr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.drudis.2007.06.011","article-title":"Drug metabolism in the paediatric population and in the elderly","volume":"12","author":"Benedetti","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cts.12843","article-title":"Pediatric Pharmacokinetics and Dose Predictions: A Report of a Satellite Meeting to the 10th Juvenile Toxicity Symposium","volume":"14","author":"Reddy","year":"2021","journal-title":"Clin. Translat Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: Key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.spen.2010.10.002","article-title":"Developmental pharmacokinetics","volume":"17","author":"Anderson","year":"2010","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1528-1157.43.s.3.5.x","article-title":"Children Versus Adults: Pharmacokinetic and Adverse-Effect Differences","volume":"43","author":"Anderson","year":"2002","journal-title":"Epilepsia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00044-024-03360-7","article-title":"CYP3A4 drug metabolism considerations in pediatric pharmacotherapy","volume":"33","author":"Luth","year":"2024","journal-title":"Med. Chem. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17562848231163410","DOI":"10.1177\/17562848231163410","article-title":"Drug-induced liver injury: A comprehensive review","volume":"16","author":"Hosack","year":"2023","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.109.162651","article-title":"Intrinsic versus idiosyncratic drug-induced hepatotoxicity\u2014Two villains or one?","volume":"332","author":"Roth","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induces liver injury: Advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1091581817721675","article-title":"Drug-induced liver injury in children: Clinical observations, animal models and regulatory status","volume":"36","author":"Shi","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"ref_30","unstructured":"Burns, M.J., Friedman, S.L., and Larson, A.M. (2024, March 14). Acetaminophen (Paracetamol) Poisoning in Adults: Pathophysiology, Presentation and Evaluation. Available online: https:\/\/www.uptodate.com\/contents\/acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-presentation-and-evaluation."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","volume":"196","author":"Hinson","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","article-title":"Acetaminophen hepatotoxicity and repair: The role of sterile inflammation and innate immunity","volume":"32","author":"Jaeschke","year":"2012","journal-title":"Liver Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"ref_34","unstructured":"(2024, March 14). Merriam-Webster. s.d. Idiosyncracy. Available online: https:\/\/www.merriam-webster.com\/dictionary\/idiosyncracy."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/pr.113.007450","article-title":"Idiosyncratic adverse drug reactions: Current concepts","volume":"65","author":"Uetrecht","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The innate immune response in idiosyncratic drug reactions","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4254\/wjh.v15.i1.52","article-title":"Liver immunity, autoimmunity and inborn error of immunity","volume":"15","author":"Parlar","year":"2023","journal-title":"World J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4254\/wjh.v13.i11.1677","article-title":"Role of immune dysfunction in drug induced liver injury","volume":"13","author":"Girish","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Moreno-Torres, M., Quintas, G., and Castell, J.V. (2022). The potential role of metabolomics in drug-induced liver injury (DILI) assessment. Metabolites, 12.","DOI":"10.3390\/metabo12060564"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","article-title":"CSH guidelines for the diagnosis and treatment of drug-induced liver injury","volume":"11","author":"Yu","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_41","unstructured":"Larson, A.M. (2023, April 10). Drug-Induced Liver Injury. Available online: https:\/\/www.uptodate.com\/contents\/drug-induced-liver-injury."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.14309\/01.ajg.0000599164.12840.16","article-title":"Carbamazepine-induced immuno-allergic hepatitis","volume":"114","author":"Daneshvar","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Drug-induced liver injury network. Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"Kosinski","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep4.1959","article-title":"Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports","volume":"6","author":"Bjornsson","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Iorga, A., Dara, L., and Kaplowitz, N. (2017). Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051018"},{"key":"ref_46","first-page":"225","article-title":"Autoantibodies and liver diseases: Use and abuses","volume":"24","author":"Zeman","year":"2010","journal-title":"Can. J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug-induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Schramm","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report","volume":"79","author":"Andrade","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_49","first-page":"145","article-title":"Immune mechanisms of idiosyncratic drug-induced liver injury","volume":"3","author":"Mak","year":"2017","journal-title":"J. Clin. Transl. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.livres.2021.02.001","article-title":"Clinical perspectives of isoniazid-induced liver injury","volume":"5","author":"Lei","year":"2021","journal-title":"Liver Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","article-title":"Regulation of drug-induced liver injury by signal transduction pathways: Critical role of mitochondria","volume":"34","author":"Han","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jat.3277","article-title":"Metabolic activation and drug-induced liver injury in vitro approaches for the safety risk assessment of new drugs","volume":"36","author":"Tolosa","year":"2016","journal-title":"J. Appl. Toxicol."},{"key":"ref_53","unstructured":"LiverTox (2024, January 18). Valproate, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548284\/."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Meseguer, E.S., Elizalde, M.U., Borobia, A.M., and Ramirez, E. (2021). Valproic acid-induced liver injury: A case-control study from a prospective pharmacovigilance program in a tertiary hospital. J. Clin. Med., 10.","DOI":"10.3390\/jcm10061153"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijep.2017.09.002","article-title":"A fatal case of valproate-induced hyperammonemic encephalopathy: An update on proposed pathogenic mechanisms and treatment options","volume":"4","author":"Wai","year":"2017","journal-title":"Int. J. Epilepsy"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","article-title":"Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives","volume":"146","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MPG.0b013e31821d6cfd","article-title":"Drug-induced liver injury network. Characteristics of idiosyncratic drug-induced liver injury in children: Results from the DILIN prospective study","volume":"53","author":"Molleston","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100321","DOI":"10.1016\/j.aohep.2021.100321","article-title":"Drug-induced liver injury: A management position paper from the Latin American Association for study of the liver","volume":"24","author":"Bessone","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_59","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol. Hepatol. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pop, T.L., Aldea, C.O., Delean, D., Bulata, B., Boghitoiu, D., Pacurar, D., Ulmeanu, C.E., and Grama, A. (2022). The role of predictive models in the assessment of the poor outcomes in pediatric acute liver failure. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020432"},{"key":"ref_61","first-page":"7","article-title":"Acetaminophen toxicity in children: Diagnosis, clinical assessment and treatment of acute overingestion","volume":"12","author":"Defendi","year":"2013","journal-title":"Consultant360"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccc.2012.07.006","article-title":"A review of acetaminophen poisoning","volume":"28","author":"Hogman","year":"2012","journal-title":"Crit. Care Clin."},{"key":"ref_63","unstructured":"Agrawal, S., and Khazawni, B. (2024, January 14). Acetaminophen Toxicity, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441917\/."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","article-title":"Drug-induced liver injury\u2014A 2023 update","volume":"26","author":"Allison","year":"2023","journal-title":"J. Toxicol. Environ. Health\u2014B Crit. Rev."},{"key":"ref_65","unstructured":"LiverTox (2024, March 20). Roussel Uclaf Causality Assessment Methos (RUCAM) in Drug-Induced Liver Injury, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548272."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/17425255.2021.1999410","article-title":"Biomarkers of idiosyncratic drug-induced liver injury (DILI)\u2014A systematic review","volume":"17","author":"Atallah","year":"2021","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction","volume":"11","author":"Andrade","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cts.13424","article-title":"Genetics of drug-induced liver injury: Current knowledge and future prospects","volume":"16","author":"Daly","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/17474124.2016.1127756","article-title":"Current and future directions in the treatment and prevention of drug-induced liver injury: A systematic review","volume":"10","author":"Stine","year":"2016","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1665-2681(19)30913-5","article-title":"Drug-induced liver injury: Do we still need a routine liver biopsy for diagnosis today?","volume":"13","author":"Teschke","year":"2014","journal-title":"Ann. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/hep.26001","article-title":"Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial","volume":"57","author":"Squires","year":"2013","journal-title":"Hepatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s40264-022-01224-w","article-title":"Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review","volume":"45","author":"Niu","year":"2022","journal-title":"Drug Saf."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Grama, A., Aldea, C.O., Burac, L., Delean, D., Bulata, B., Sirbe, C., Duca, E., Boghitoiu, D., Coroleuca, A., and Pop, T.L. (2020). Etiology and outcome after acute liver failure in children\u2014The experience of a single tertiary care hospital from Romania. Children, 7.","DOI":"10.3390\/children7120282"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17425255.2023.2223959","article-title":"Paracetamol (acetaminophen) overdose and hepatotoxicity: Mechanism, treatment, prevention measures, and estimates of burden of disease","volume":"19","author":"Chidian","year":"2023","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_75","unstructured":"Heard, K., and Dart, R. (2024, March 25). Acetaminophen (Paracetamol) Poisoning: Management in Adults and Children. Available online: https:\/\/www.uptodate.com\/contents\/acetaminophen-paracetamol-poisoning-management-in-adults-and-children."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1542\/hpeds.2021-005816","article-title":"US Hospital stays in children and adolescents with acetaminophen poisoning","volume":"12","author":"Shadman","year":"2022","journal-title":"Hosp. Pediatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/archpedi.154.4.346","article-title":"Pediatric Acetaminophen overdose: Risk factors associated with hepatocellular injury","volume":"154","author":"Alander","year":"2000","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/pch\/16.9.544","article-title":"The proper use of acetaminophen","volume":"16","author":"James","year":"2011","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mpd.2000.107624","article-title":"Why young children are resistant to acetaminophen poisoning","volume":"137","author":"Tenenbein","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Daifallah, A., Jabr, R., Al-Tawil, F., Elkourdi, M., Salman, Z., Koni, A., Samara, A., Al-Jabi, S.W., and Zyoud, S.H. (2021). An assessment of parents\u2019 knowledge and awareness regarding paracetamol use in children: A cross-sectional study from Palestine. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-10432-5"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clinthera.2006.05.010","article-title":"Determinants of antipyretic misuse in children up to 5 years of age: A cross-sectional study","volume":"28","author":"Bilenko","year":"2006","journal-title":"Clin. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1179\/1973947813Y.0000000090","article-title":"Antibiotic induced liver injury: What about children?","volume":"25","author":"Serranti","year":"2013","journal-title":"J. Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.21037\/atm-20-5144","article-title":"Prevalence and clinical characteristics of antibiotics associated drug-induced liver injury","volume":"9","author":"Park","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Meesters, K., Chappell, F., and Demirjian, A. (2024). Trends in antibiotic use in a large children\u2019s hospital in London (United Kingdom): 5 years of point prevalence surveys. Antibiotics, 13.","DOI":"10.3390\/antibiotics13020172"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4314\/ahs.v18i4.40","article-title":"Evaluation of antibiotic prescriptions and use in under-five children in Ibadan, South Western Nigeria","volume":"18","author":"Adisa","year":"2018","journal-title":"Afr. Health Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.aohep.2023.101044","article-title":"Amoxicillin-clavulanate induced liver injury: Ten years experience from LATINDILI registry","volume":"28","author":"Hernandez","year":"2023","journal-title":"Ann. Hepatol."},{"key":"ref_87","first-page":"711","article-title":"Amoxicillin-clavulanate induced DILI: 113 cases from the US Drug-Induced Liver Injury Network (DILIN)","volume":"60","author":"Ghabril","year":"2014","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkr159","article-title":"Hepatic safety of antibiotics used in primary care","volume":"66","author":"Andrade","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"112664","DOI":"10.1016\/j.fct.2021.112664","article-title":"Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways","volume":"158","author":"Petrov","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.anpedi.2012.06.012","article-title":"Hepatotoxicidad por farmacos o productos naturales en ninos [Hepatotoxicity due to drugs or natural products in children]","volume":"78","author":"Garcis","year":"2013","journal-title":"An. Pediatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_93","unstructured":"CDC (2023, May 11). Outpatient Antibiotic Prescriptions\u2014United States, Available online: https:\/\/www.cdc.gov\/antibiotic-use\/data\/report-2022.html."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug induced liver injury: A population based case-control study","volume":"58","author":"Montero","year":"2004","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1440-1754.2007.01278.x","article-title":"Reversible oxacillin-associated hepatitis in a 9-month-old boy","volume":"44","author":"Lee","year":"2008","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/jac\/dkac325","article-title":"Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins","volume":"77","author":"Tang","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5009\/gnl14184","article-title":"Causes, features and outcomes of drug-induced liver injury in 69 children from China","volume":"9","author":"Zhu","year":"2015","journal-title":"Gut Liver"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1665-2681(19)31645-X","article-title":"Cefuroxime axetil-induced liver failure","volume":"9","author":"Ekiz","year":"2010","journal-title":"Ann. Hepatol."},{"key":"ref_99","first-page":"e5036","article-title":"Cefuroxime-induced hepatocellular-cholestatic hepatitis with pancytopenia","volume":"6","author":"Kunze","year":"2019","journal-title":"Open Access Lib. J."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Castellazzi, M.L., Agostoni, C.V., Palella, J., Civeriati, D., Marchisio, P., and Nebbia, G. (2022). Ceftriaxone-induced cholestatic hepatitis in a child: A case report and a review of the literature. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.1051887"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4103\/jfmpc.jfmpc_1133_19","article-title":"Cephalosporin\u2019s induced hepatic enzyme derangement\u2014An educational report","volume":"9","author":"Thangaraju","year":"2020","journal-title":"J. Family Med. Prim. Care"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/INF.0000000000004209","article-title":"Cefepime-induced acute liver injury in a 5-year-old boy","volume":"43","author":"Mode","year":"2024","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/archdischild-2019-317950","article-title":"Safety of ceftriaxone in paediatrics: A systematic review","volume":"105","author":"Zeng","year":"2020","journal-title":"Arch. Dis. Child."},{"key":"ref_104","first-page":"e080108","article-title":"Pharmacological treatment of ceftriaxone-related cholelithiasis in children: Is it worthwhile?","volume":"8","author":"Oggiano","year":"2019","journal-title":"J. Pediatr. Neonatal Individ. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/0016-5085(92)90346-Z","article-title":"Prolonged cholestasis due to trimethoprim-sulfamethoxazole","volume":"102","author":"Kowdley","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.14309\/ajg.0000000000002232","article-title":"The impact of patient age and corticosteroids in patients with sulfonamide hepatotoxicity","volume":"118","author":"Fontana","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/INF.0000000000002664","article-title":"Trimethoprim-Sulfamethoxazole associated drug-induced liver injury in pediatrics: A systematic review","volume":"39","author":"Burgos","year":"2020","journal-title":"Pediatr. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"ref_109","unstructured":"LiverTox (2024, March 15). Nitrofurantoin, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548318\/."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2022.09.010","article-title":"Clinical features, outcomes and HLA risk factors associated with nitrofurantoin-induced liver injury","volume":"78","author":"Chalasani","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00204-022-03419-7","article-title":"Nitrofurantoin-induced liver injury: Long term follow-up in two prospective DILI registries","volume":"97","author":"Bessone","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.ju.0000130653.74548.d6","article-title":"Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children","volume":"172","author":"Karpman","year":"2004","journal-title":"J. Urol."},{"key":"ref_113","unstructured":"Nazarian, S., and Akhondi, H. (2024, March 11). Minocycline, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554519\/."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an antibiotic","volume":"169","author":"Zarzuelo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Clemens, V., Regert, F., Le Bret, N., Heuser, I., and Hellman-Regen, J. (2018). Anti-inflammatory effects of minocycline are mediated by retinoid signaling. BMC Neurosci., 19.","DOI":"10.1186\/s12868-018-0460-x"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Grieco, J.C., Ciarlone, S.L., Gieron-Korthals, M., Schoengerg, M.R., Smith, A.G., Philpot, R.M., Heussler, H.S., Banko, J.L., and Weeber, E.J. (2014). An open-label pilot trial of minocycline in children as a treatament for Angelman syndrome. BMC Neurol., 14.","DOI":"10.1186\/s12883-014-0232-x"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_118","first-page":"740","article-title":"Acne Vulgaris: Treatment Guidelines from the AAD","volume":"95","author":"Hauk","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2125.2010.03754.x","article-title":"Drug-induced hepatic injury in children: A case\/non-case study of suspected adverse drug reactions in VigiBase","volume":"70","author":"Ferrajolo","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MPG.0000000000002383","article-title":"Antimicrobials and antiepileptics are the leading causes of idiosyncratic drug-induced liver injury in american children","volume":"69","author":"DiPaola","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5223\/pghn.2018.21.4.347","article-title":"Minocycline-induced autoimmune hepatitis: A rare but important cause of drug-induced autoimmune hepatitis","volume":"21","author":"Harmon","year":"2018","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11095-019-2582-y","article-title":"Analyzing the mechanisms behind macrolide antibiotic-induced liver injury using quantitative systems toxicology modeling","volume":"36","author":"Woodhead","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_123","unstructured":"LiverTox (2024, April 22). Azithromycin, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548434\/."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2014.07.054","article-title":"Clinical and histologic features of azithromycin-induced liver injury","volume":"13","author":"Martinez","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Tchakounte Youngui, B., Tchounga, B.K., Graham, S.M., and Bonnet, M. (2022). Tuberculosis infection in children and adolescents. Pathogens, 11.","DOI":"10.3390\/pathogens11121512"},{"key":"ref_126","unstructured":"WHO (2022). WHO Consolidated Guidelines on Tuberculosis. Module 5: Management of Tuberculosis in Children and Adolescents, World Health Organization. Vers. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/INF.0000000000002192","article-title":"Antituberculosis drug-induced liver injury in children: Incidence and risk factors during two-month intensive phase of therapy","volume":"38","author":"Gafar","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1665-2681(19)31492-9","article-title":"Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy","volume":"11","author":"Mansukhani","year":"2012","journal-title":"Ann. Hepatol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Shang, P., Xia, Y., Liu, F., Wang, X., Yuan, Y., Hu, D., Tu, D., Chen, Y., Deng, P., and Cheng, S. (2011). Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ALTI) in China. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021836"},{"key":"ref_130","first-page":"117","article-title":"Anti-tuberculosis therapy induced hepatotoxicity in children","volume":"37","author":"Hotchandani","year":"2013","journal-title":"Pak. Pediatr. J."},{"key":"ref_131","first-page":"45","article-title":"Analysis of status and influencing factors associated with anti-tuberculosis drug-related liver injury in children","volume":"45","author":"Chen","year":"2023","journal-title":"Chin. J. Antituberc."},{"key":"ref_132","unstructured":"D\u2019Orazio, J.L. (2024, May 18). Isoniazid Toxicity. Available online: https:\/\/emedicine.medscape.com\/article\/180554-overview#a3."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Liu, Y., Li, H., Huang, L., Wan, C., Wang, H., Jiao, X., Zeng, L., Jia, Z., Cheng, G., and Zhang, L. (2023). Liver injury in children: Signal analysis of suspected drugs based on the food and drug administration adverse event reporting system. BMC Pediatr., 23.","DOI":"10.1186\/s12887-023-04097-9"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jaip.2018.07.003","article-title":"Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects","volume":"6","author":"Kuyucu","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_135","first-page":"357","article-title":"Valproic acid for children below 2 years of age with epilepsy","volume":"26","author":"Muthaffar","year":"2021","journal-title":"Neurosci. J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.seizure.2005.12.009","article-title":"Antiepileptis drugs and liver disease","volume":"15","author":"Siddiqi","year":"2006","journal-title":"Seizure\u2014Eur. J. Epilep"},{"key":"ref_137","unstructured":"LiverTox (2024, May 17). Phenytoin, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548889\/."},{"key":"ref_138","unstructured":"LiverTox (2024, May 17). Carbamazepine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548097\/."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jhep.2021.12.013","article-title":"Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study","volume":"76","author":"Chalasani","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/hep.28270","article-title":"Drug-induced liver injury associated with Stevens-Johnson syndrome\/toxic epidermal necrolysis: Pateint characteristics, causes and outcome in 36 cases","volume":"63","author":"Devarbhavi","year":"2016","journal-title":"Hepatology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jpc.16200","article-title":"Carbamazepine-induced liver injury in an 11-year-old female: Case report and review of the literature","volume":"59","author":"Amos","year":"2023","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_142","unstructured":"LiverTox (2024, May 17). Phenobarbital, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548269\/."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Star, K., Edwards, I.R., and Choonara, I. (2014). Valproic acid and fatalities in children: A review of individual case safety reports in VigiBase. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108970"},{"key":"ref_144","unstructured":"LiverTox (2024, May 17). Lamotrigine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548562\/."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"107832","DOI":"10.1016\/j.yebeh.2021.107832","article-title":"Drug-induced liver injury associated with antiseizure medications from the FDA adverse event reporting system (FAERS)","volume":"117","author":"Kamitaki","year":"2021","journal-title":"Epilepsy Behav."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"100568","DOI":"10.1016\/j.ebr.2022.100568","article-title":"Acute liver failure associated with lamotrigine in children with epilepsy: A report of two cases and thoughts on pharmacogenomics","volume":"20","author":"Deng","year":"2022","journal-title":"Epilepsy Behav. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e255787","DOI":"10.1136\/bcr-2023-255787","article-title":"Periportal necrosis and successful liver transplantation following lamotrigine drug-induced liver injury in a child","volume":"16","author":"Couper","year":"2023","journal-title":"BMJ Case Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0887-8994(97)00196-3","article-title":"Acute hepatic failure in a child treated with lamotrigine","volume":"18","author":"Arnon","year":"1998","journal-title":"Pediatr. Neurol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17425255.2024.2322114","article-title":"Hepatotoxicity of newer antiseizure medications in children: An overview and disproportionality analysis of VigiBase","volume":"20","author":"Petrovic","year":"2024","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.3748\/wjg.v16.i45.5651","article-title":"Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?","volume":"16","author":"Bessone","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_151","unstructured":"Ghlichloo, I., and Gerriets, V. (2024, April 24). Nonsteroidal Antiinflammatory Drugs (NSAIDs), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547742\/."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.327.7405.18","article-title":"Cohort study of hepatotoxicity associated with simesulide and other non-steroidal anti-inflammatory drugs","volume":"327","author":"Traversa","year":"2003","journal-title":"BMJ"},{"key":"ref_153","unstructured":"Kopp, C. (2024, April 28). Nimesulide Must Be Withdrawn Worldwide Due to Serious Liver Damage. Available online: https:\/\/www.ti.ubc.ca\/2008\/02\/04\/nimesulide-must-be-withdrawn-worldwide-due-serious-liver-damage\/."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5604\/01.3001.0010.8633","article-title":"Recent advancement in hepatotoxicity of non-steroidal anti-inflammatory drugs","volume":"17","author":"Meunier","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_155","first-page":"21","article-title":"Topical Diclofenac induced hepatotoxicity","volume":"13","author":"Delungahawatta","year":"2023","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_156","unstructured":"LiverTox (2024, April 20). Ibuprofen, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547845\/."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/apt.15645","article-title":"Systematic review: Ibuprofen-induced liver injury","volume":"51","author":"Zoubek","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.21037\/tp-21-8","article-title":"Ibuprofen induced Stevens-Johnson syndrome and liver injury in children: A case report","volume":"10","author":"Gui","year":"2021","journal-title":"Transl. Pediatr."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajg.2016.08.006","article-title":"Acute vanishing bile duct syndrome after the use of ibuprofen","volume":"17","author":"Basturk","year":"2016","journal-title":"Arab. J. Gastroenterol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3349\/ymj.2014.55.3.834","article-title":"Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpeds.2004.05.027","article-title":"Acute vanishing bile duct syndrome after ibuprofen therapy in a child","volume":"145","author":"Taghian","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0016-5085(98)70154-4","article-title":"Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndrome in a child: A case report","volume":"115","author":"Srivastava","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_163","unstructured":"Barnett, A.K., and Boyer, E.W. (2024, April 20). Salicylate (Aspirin) Poisoning: Clinical Manifestations and Evaluation. Available online: https:\/\/www.uptodate.com\/contents\/salicylate-aspirin-poisoning-clinical-manifestations-and-evaluation."},{"key":"ref_164","first-page":"HS6","article-title":"Reye\u2019s Syndrome: A Rare but Serious Pediatric Condition","volume":"37","author":"Degnan","year":"2012","journal-title":"US Pharm."},{"key":"ref_165","unstructured":"Chapman, K., and Arnold, J.K. (2024, April 24). Reye Syndrome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526101\/."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/adc.85.5.351","article-title":"Reye syndrome-insights on causation and prognosis","volume":"85","author":"Glasgow","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"ref_167","first-page":"185","article-title":"Reye\u2019s Syndrome Arising from the Treatment of Kawasaki Disease","volume":"23","author":"Su","year":"2018","journal-title":"HK J. Paediatr."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14776\/kjpid.2012.19.2.79","article-title":"A case of Reye syndrome following treatment of Kawasaki disease with aspirin","volume":"19","author":"Lee","year":"2012","journal-title":"Korean J. Pediatr. Infect. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1754.2005.00617.x","article-title":"Reye\u2019s syndrome developing in an infant on treatment of Kawasaki syndrome","volume":"41","author":"Wei","year":"2005","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s10067-020-05534-1","article-title":"Kawasaki disease and influenza\u2014New lessons from old associations","volume":"40","author":"Banday","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13052-021-00962-4","article-title":"Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease","volume":"47","author":"Marchesi","year":"2021","journal-title":"Ital. J. Pediatr."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM199905063401801","article-title":"Reye\u2019s syndrome in the United States from 1981 through 1997","volume":"340","author":"Belay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_173","unstructured":"Kanwar, V.S. (2024, June 22). Pediatric Acute Lymphoblastic Leukemia. Available online: https:\/\/emedicine.medscape.com\/article\/990113."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia. Version 2.2020. NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_175","first-page":"3461","article-title":"Management of hepatotoxicity of chemotherapy and targeted agents","volume":"11","author":"Mudd","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_176","first-page":"37","article-title":"Chemotherapy induced liver toxicity in children with malignant diseases","volume":"91","author":"Horvath","year":"2019","journal-title":"Bull. Med. Sci."},{"key":"ref_177","first-page":"256","article-title":"Lesion hepatica inducida pot quimioterapia en ninos [Chemotherapy-induced liver injury in children]","volume":"91","author":"Luque","year":"2019","journal-title":"An. Pediatr."},{"key":"ref_178","first-page":"5914593","article-title":"Drug-induced liver injury during consolidation therapy in childhood acute lymphoblastic leukemia as assessed for causality usinf the updated RUCAM","volume":"2022","author":"Qin","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.jhepr.2024.101102","article-title":"Drug induced liver injury in children: A nationwide cohort study from China","volume":"6","author":"Lai","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/apa.15120","article-title":"Liver injury in children with long-term low-dose methotrexate","volume":"109","author":"Kelgeri","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0022-3476(77)80587-8","article-title":"Methotrexate hepatotoxicity in children with leukemia","volume":"90","author":"McIntosh","year":"1977","journal-title":"J. Pediatr."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1097-0142(196003\/04)13:2<288::AID-CNCR2820130213>3.0.CO;2-L","article-title":"Hepatic fibrosis in children with acute leukemia: A complication of therapy","volume":"13","author":"Hutter","year":"1960","journal-title":"Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Schmidt, S., Messner, C.J., Gaiser, C., Hammerli, C., and Suter-Dick, L. (2022). Methotrexate-induced liver injury is associated with oxidative stress, impaired mitochondrial respiration and endoplasmic reticulum stress in vitro. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315116"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00431-023-05267-8","article-title":"Effects of gene polymorphism on delayed MTX clearance, toxicity and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia","volume":"183","author":"Zhou","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_185","unstructured":"LiverTox (2024, June 25). Mercaptopurine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548546\/."},{"key":"ref_186","unstructured":"Sacerdotianu, V.M., Streba, C.T., Rogoveanu, I., Streba, L., and Vere, C.C. (2024, May 20). Oncological Therapy-Associated Liver Injuries. Available online: https:\/\/www.intechopen.com\/chapters\/83031."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1665-2681(19)31651-5","article-title":"Effects of systemic chemotherapy on the liver","volume":"9","author":"Ramadori","year":"2010","journal-title":"Ann. Hepatol."},{"key":"ref_188","unstructured":"Corbacioglu, S. (2024, May 20). Hepatic Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in Children. Available online: https:\/\/www.uptodate.com\/contents\/hepatic-sinusoidal-obstruction-syndrome-veno-occlusive-disease-in-children."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e130336","DOI":"10.5812\/ijpr-130336","article-title":"Hepatotoxicity induced by azole antifungal agents: A review study","volume":"22","author":"Rakhshan","year":"2023","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_190","unstructured":"LiverTox (2024, May 20). Fluconazole, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548300\/."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Zhou, Z.X., Yin, X.D., Zhang, Y., Shao, Q.H., Mao, X.Y., Hu, W.J., Shen, Y.L., Zhao, B., and Li, Z.L. (2022). Antifungal drugs and drug-induced liver injury: A real-world study leveraging the FDA Adverse Event Reporting System database. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.891336"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4254\/wjh.v6.i8.601","article-title":"Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database","volume":"6","author":"Raschi","year":"2014","journal-title":"World J. Hepatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"325","DOI":"10.30621\/jbachs.1051669","article-title":"Voriconazole-induced hepatotoxicity concise up-to-date review","volume":"6","author":"Ertem","year":"2022","journal-title":"J. Basic. Clin. Health Sci."},{"key":"ref_195","first-page":"e18940","article-title":"Systematic review of antifungal-induced acute liver failure","volume":"13","author":"Gadour","year":"2021","journal-title":"Cureus"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Doss, S., Potschka, H., Doss, F., Mitzner, S., and Sauer, M. (2017). Hepatotoxicity of antimycotics used for invasive fungal infections: In vitro results. Biomed. Res. Int., 2017.","DOI":"10.1155\/2017\/9658018"},{"key":"ref_197","unstructured":"Dongmo Fotsing, L.N., and Bajaj, T. (2024, May 25). Caspofungin, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545140\/."},{"key":"ref_198","unstructured":"LiverTox (2024, May 25). Echinocandins, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548299\/."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s15010-006-5657-8","article-title":"Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients","volume":"34","author":"Saner","year":"2006","journal-title":"Infection"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bmt.1704516","article-title":"Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections","volume":"34","author":"Jurado","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/INF.0b013e318067b4d1","article-title":"Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children","volume":"26","author":"Koo","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_202","unstructured":"Powderly, D.J., Opal, W.G., and Cohen, S.M. (2017). Antiparasitic agents. Infectious Diseases, Elsevier."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1473-3099(22)00026-3","article-title":"Mass drug administration of ivermectin, diethylcarbamazepine, plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: A cluster-randomised trial","volume":"22","author":"Laman","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_204","unstructured":"Malik, K., and Dua, A. (2024, January 10). Albendazole, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553082\/."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jac\/dki484","article-title":"Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: In vitro studies","volume":"57","author":"Palomares","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.bpj.2010.06.065","article-title":"Mechanics of microtubules: Effects of protofilament orientation","volume":"99","author":"Donhauser","year":"2010","journal-title":"Biophys. J."},{"key":"ref_207","unstructured":"Cooper, G.M. (2000). The Cell: A Molecular Approach, Sinauer Associates. [2nd ed.]."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.exppara.2008.07.008","article-title":"Taenia crassiceps: Energetic and respiratory metabolism from cysticerci exposed to praziquantel and albendazole in vitro","volume":"120","author":"Vinaud","year":"2008","journal-title":"Exp. Parasitol."},{"key":"ref_209","unstructured":"LiverTox (2024, January 10). Albendazole, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548360\/."},{"key":"ref_210","first-page":"84","article-title":"Acute liver failure secondary to toxic exposure in children","volume":"18","author":"Grama","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Dijmarescu, I., Guta, O.M., Brezeanu, L.E., Dijmarescu, A.D., Becheanu, C.M., and Pacurar, D. (2022). Drug-induced hepatitis in children: The experience of a single center in Romania. Children, 9.","DOI":"10.3390\/children9081136"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s13312-013-0285-8","article-title":"Albendazole-induced recurrent hepatitis","volume":"50","author":"Nandi","year":"2013","journal-title":"Indian Pediatr."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7869\/tg.2012.90","article-title":"Recurrent acute hepatitis caused by albendazole","volume":"34","author":"Shah","year":"2013","journal-title":"Trop. Gastroenterol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3855\/jidc.16594","article-title":"Acute hepatitis in a paediatric patient: Immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?","volume":"16","author":"Dragutinovic","year":"2022","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","article-title":"The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses","volume":"339","author":"Ayano","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/10870547211036754","article-title":"The adverse health outcomes, economic burden and public health implications of unmanaged attention deficit hyperactivity disorder (ADHD): A call to action resulting from CHADD summit, Washington, DC, October 17, 2019","volume":"26","author":"Cattoi","year":"2022","journal-title":"J. Atten. Disord."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"e201922528","DOI":"10.1542\/peds.2019-2528","article-title":"Clinical practice guideline for the diagnosis, evaluation and treatment of attention deficit\/hyperactivity disorder in children and adolescents","volume":"144","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"key":"ref_218","unstructured":"LiverTox (2024, January 25). Atomoxetine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548671\/."},{"key":"ref_219","first-page":"456","article-title":"Diagnosis and management of ADHD in children","volume":"90","author":"Felt","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15563650600795644","article-title":"Atomoxetine-induced hepatitis in a child","volume":"45","author":"Stojanovski","year":"2007","journal-title":"Clin. Toxicol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-200831040-00008","article-title":"Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder","volume":"31","author":"Bangs","year":"2008","journal-title":"Drug Saf."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/cap.2010.0101","article-title":"Idiosyncratic liver failure probably associated with atomoxetine: A case report","volume":"21","author":"Erdogan","year":"2011","journal-title":"J. Child. Adolesc. Pshychopharmacol."},{"key":"ref_223","first-page":"e15","article-title":"Drug-induced liver injury in children: Atomoxetine and nonstimulants for ADHD","volume":"7","author":"Potnis","year":"2015","journal-title":"Am. J. Pharm. Benefits"},{"key":"ref_224","unstructured":"Ahmed, A., and Clarke, J.O. (2024, May 28). Proton Pump Inhibitors (PPI), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557385\/."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Dipasquale, V., Cicala, G., Spina, E., and Romano, C. (2022). A narrative review on efficacy and safety of proton pump inhibitors in children. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.839972"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/postgradmedj-2020-138838","article-title":"Pantoprazole-induced acute hepatocellular and cholestatic hepatitis","volume":"98","author":"Kataria","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_227","first-page":"3421","article-title":"Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report","volume":"8","author":"Ata","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.14309\/00000434-201810001-02421","article-title":"Proton pump inhibitor-induced liver injury","volume":"113","author":"Alhankawi","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.pec.0000173350.45648.9b","article-title":"Omeprazole-induced hepatitis","volume":"21","author":"Dalzell","year":"2005","journal-title":"Pediatr. Emerg. Care"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Yu, Y., Nie, X., Song, Z., Xie, Y., Zhang, X., Du, Z., Wei, R., Fan, D., Liu, Y., and Zhao, O. (2020). Signal detection of potentially drug-induced liver injury in children using electronic health records. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.00171"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:42:19Z","timestamp":1760028139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":230,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26052006"],"URL":"https:\/\/doi.org\/10.3390\/ijms26052006","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}